Pharmabiz

Hong Kong Department of Health approves IASO Bio’s’ Fucaso to treat relapsed or refractory multiple myeloma

Hong Kong Department of Health approves IASO Bio’s’ Fucaso to treat relapsed or refractory multiple myeloma: Shanghai, Nanjing Friday, November 28, 2025, 14:00 Hrs [IST] IASO ...
Pharmabiz

Renalys Pharma reports positive results from phase III study of sparsentan in Japanese patients with IgA nephropathy

Renalys Pharma reports positive results from phase III study of sparsentan in Japanese patients with IgA nephropathy: Tokyo, Japan Friday, November 28, 2025, 13:00 Hrs [IST] Renal ...
Pharmabiz

Global pioneer Prof B S Bhoop wins prestigious IPA Eminent Pharmacist Award 2025

Global pioneer Prof B S Bhoop wins prestigious IPA Eminent Pharmacist Award 2025: Our Bureau, Chennai Friday, November 28, ...
Pharmabiz

Cothera Bioscience’s zotiraciclib for treatment of recurrent high-grade glioma receives US FDA fast track designation

Cothera Bioscience’s zotiraciclib for treatment of recurrent high-grade glioma receives US FDA fast track designation: San Mateo, California Friday, November 28, 2025, 12:00 Hrs ...
Pharmabiz

Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval

Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval: Our Bureau, Mumbai Friday, November 28, 2025, 11:40 Hrs [IST] Sun Pharmaceutical Industries Limited ann ...
Pharmabiz

WHO releases policy brief on priority setting in TB programme planning

WHO releases policy brief on priority setting in TB programme planning: Geneva Friday, November 28, 2025, 11:00 Hrs [IST] The World Health Organization (WHO) has released a new po ...
Pharmabiz

TempraMed Technologies inks exclusive distribution agreement with Guri to market TempraMed's products across Israel

TempraMed Technologies inks exclusive distribution agreement with Guri to market TempraMed's products across Israel: Vancouver, British Columbia Friday, November 28, 2025, 10:00 H ...
Pharmabiz

US FDA accepts and grants priority review status to BeOne Medicines’ sonrotoclax to treat relapsed or refractory mantle cell lymphoma

US FDA accepts and grants priority review status to BeOne Medicines’ sonrotoclax to treat relapsed or refractory mantle cell lymphoma: San Carlos, California Friday, November 28 ...
Pharmabiz

High level Ethiopian delegation visits Telangana to study drug regulatory excellence

High level Ethiopian delegation visits Telangana to study drug regulatory excellence: Peethaambaran Kunnathoor, Chennai ...
Pharmabiz

IPC to train small-scale pharma & medtech firms in strengthening PV & MV reporting for patient safety

IPC to train small-scale pharma & medtech firms in strengthening PV & MV reporting for patient safety: Shardul Nautiyal, Mumbai Friday, November 28, 2025, 08:00 Hrs [IST] The Indi ...
Opinion
PharmabizOpinion

India must fast-track talent training pipelines to power next wave of cell & gene therapy: Dr Hingorani

India must fast-track talent training pipelines to power next wave of cell & gene therapy: Dr Hingorani: Nandita Vijayasimha, Bengaluru Friday, November 28, 2025, 08:00 Hrs [IST] ...
Pharmabiz

Credit guarantee scheme to help maintain cash flow and financial stability for pharma exporters: Experts

Credit guarantee scheme to help maintain cash flow and financial stability for pharma exporters: Experts: Shardul Nautiyal, Mumbai Friday, November 28, 2025, 08:00 Hrs [IST] The C ...